BISPIT Liver Restoration Tablets

Manufacturer
Bispit Canada Ltd.
Effective date
2025-06-06
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 02:33:55

Label at a glance#

ProductBispit Canada Ltd.
Active ingredientEPIMEDIUM PUBESCENS WHOLE, BLACK PEPPER, TARAXACUM MONGOLICUM, PUERARIA MONTANA VAR. LOBATA ROOT, CHITOSAN OLIGOSACCHARIDE, SCHISANDRA CHINENSIS WHOLE, SILYBUM MARIANUM WHOLE, GANODERMA LUCIDUM WHOLE, TAURINE, LICORICE
Label structure9 sections

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

SILYBUM MARIANUM WHOLE
SCHISANDRA CHINENSIS WHOLE
EPIMEDIUM PUBESCENS WHOLE
TARAXACUM MONGOLICUM WHOLE
BLACK PEPPER
PUERARIA MONTANA VAR. LOBATA ROOT
LICORICE
GANODERMA LUCIDUM WHOLE
CHITOSAN OLIGOSACCHARIDE
TAURINE

PURPOSE

OTC - PURPOSE SECTION

This product helps protect the liver from chemical injury. ltcan promote the repair and regeneration of damagedliver cells, improve liver function, nourish and protect theorgan, enhance liver detoxification, and reduce damageto the liver caused by viral factors.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children

DOSAGE & ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Dosage:Oral administration, onetablet in the morning, onetablet in the evening (2tablets daily)

INDICATIONS & USAGE

INDICATIONS & USAGE SECTION

This product is suitable for people at high risk ofchemical liver injury or those who have alreadydeveloped symptoms of injury, including:
1. Long-term medication usersPatients who need to take liver-toxic drugs for a long timesuch as antibiotics, anti-tuberculosis drugs, and anti-tumordrugs.
2.Occupationally exposed individualsThose who work in chemical factories or laboratories or areat increased risk of liver injury due to exposure to chemicalssuch as benzene and heavy metals.
3. individuals with unhealthy lifestylesSub-healthy individuals who drink alcohol regularly, consumehigh-fat diets, or are exposed to environmental pollutants(such as haze and pollution caused by decoration materials).
4. Those seeking supportive treatmentIndividuals diagnosed with mild chemical liver injury whofollow physicians" recommendations in liver repair andconditioning.

WARNINGS

WARNINGS SECTION

Pregnant women, breastfeeding women, and those withsevere liver or kidney dysfunction should use this productunder the guidance of a physician.

This product is not a substitute for drugs. Seek medicalattention promptly if severe symptoms such as jaundice orascites occur.

OTHER SAFETY INFORMATION

Storage: Store in a tightlysealed container in a cool,dry place.

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

MICROCRYSTALLINE CELLULOSE
MALTOSYL-ISOMALTOTETRAOSE
CALCIUM CARBONATE
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED
MAGNESIUM STEARATE

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

85631-002-0185631-002-01

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
85631-002-01Bispit Canada Ltd.60 in 1 BOTTLETABLET601
85631-002-01Bispit Canada Ltd.1.2 g in 1 CARTONTABLET1.21

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
85631-00285631-002-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Bispit Canada Ltd.BISPIT LIVER RESTORATION TABLETSBispit Canada Ltd.36e35682-57cb-f60f-e063-6394a90aafa52025-06-06WarningsExact identifier
ndc (package): 85631-002-01
ndc (product): 85631-002
ndc11 (package): 85631000201
spl id: 36e35682-57cc-f60f-e063-6394a90aafa5
spl set id: 36e35682-57cb-f60f-e063-6394a90aafa5

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.